Related Experiment Video

Updated: Aug 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Pneumocystis pneumonia in infants]

M Craiu1, Iustina Stan, I Cernătescu

  • 1Institutul de Ocrotire a Mamei şi Copilului, Alfred Rusescu, Clinica 1 Pediatrie. mcraiu@yahoo.com

Pneumologia (Bucharest, Romania)
|March 16, 2006
PubMed

Insights

Pneumocystis infection (PCP) is rare in infants but presents with severe respiratory distress. Early diagnosis and treatment, including ventilation and Co-trimoxazole, significantly improve survival rates, especially in vulnerable infants.

Area of Science:

  • Pediatric Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Context:

  • Pneumocystis pneumonia (PCP) is an opportunistic infection that can be severe in infants.
  • This study focuses on infants admitted to a specific clinic between 2004 and 2005.
  • PCP incidence was observed at 1.5 per 1000 pediatric admissions.

Purpose:

  • To describe the clinical and evolutive features of Pneumocystis infection in hospitalized infants.
  • To identify risk factors, diagnostic methods, and treatment outcomes for infant PCP.
  • To understand the impact of socioeconomic factors, such as abandonment, on PCP presentation.

Summary:

  • The study analyzed 17 infant cases (10 male, 7 female) with PCP, with risk factors including prematurity, low birth weight, and abandonment.
  • Key clinical signs included tachypnea, dyspnea, cyanosis, and diffuse pulmonary involvement on radiography; pneumothorax and pneumomediastinum were noted complications.
  • Diagnosis was confirmed via microscopic examination of respiratory secretions; treatment involved mechanical ventilation and intravenous Co-trimoxazole, resulting in an 85.7% survival rate.

Impact:

  • Highlights the severity of PCP in non-HIV-infected infants, particularly those from disadvantaged backgrounds.
  • Emphasizes the importance of prompt diagnosis and aggressive management, including respiratory support.
  • Suggests a potential link between increased PCP cases and the prevalence of abandoned children in institutional care.

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: